Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Neoplasms
Interventions: BIOLOGICAL: SCT200
Sponsor: Sinocelltech Ltd.